https://www.fiercebiotech.com/biotech/qlaris-sees-double-drug-reduces-eye-pressure-pair-phase-2-trials
Qlaris sees double as drug reduces eye pressure in ph. 2 trials
Feb 5, 2025 - Qlaris Bio hit the primary endpoints in two mid-stage trials that both spanned primary open-angle glaucoma and ocular hypertension.
https://qlaris.bio/
Qlaris Bio
bio